Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05464810
Title Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Emory University
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole + Simvastatin

Letrozole

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.